Algo version: 0.98b
Luye Pharma Group Ltd is listed at the HKSE Exchange
Luye Pharma Group Ltd [2186.HK]
HKSE Sector: Industry:Pharmaceuticals, Biotechnology & Life Sciences

Is Luye Pharma Group Ltd stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Luye Pharma Group Ltd pays dividends. Last time was Friday 31st of July 2020 where the investors holding the stock on Monday 29th of June 2020 were paid HKD0.06 per share. Over the last 8 times between 2016 and 2020, Luye Pharma Group Ltd has paid HKD0.406 with an average of HKD0.05 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Luye Pharma Group Ltd 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was HKD6.11, you would have made a loss of HKD-3.06 per share or -50.08%

Yes, the average daily trading liquidity for Luye Pharma Group Ltd is HKD9.24 million. You should therefore be able to get in and out of your positions relatively fast.

Luye Pharma Group Ltd has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.19, the company's ability to pay off the debt is normal. Luye Pharma Group Ltd has a good net profit margin of 8.67% and should have high tolerances against inflation.

We have calculated the inflation risk for Luye Pharma Group Ltd to be low [0.4 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.